Skip to main content
Top
Published in: Annals of Hematology 2/2015

01-02-2015 | Letter to the Editor

Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host disease

Authors: Dominik Bettinger, Elisabeth Schorb, Daniela Huzly, Marcus Panning, Annette Schmitt-Graeff, Philipp Kurz, Hartmut Bertz, Jürgen Finke, Volker Brass, Robert Thimme, Peter Hasselblatt

Published in: Annals of Hematology | Issue 2/2015

Login to get access

Excerpt

Dear Editor, …
Literature
2.
go back to reference Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D’Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V (2014) Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 370(12):1111–1120PubMedCrossRef Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D’Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V (2014) Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 370(12):1111–1120PubMedCrossRef
3.
go back to reference Huzly D, Umhau M, Bettinger D, Cathomen T, Emmerich F, Hasselblatt P, Hengel H, Herzog R, Kappert O, Maassen S, Schorb E, Schulz-Huotari C, Thimme R, Unmussig R, Wenzel J, Panning M (2014) Transfusion-transmitted hepatitis E in Germany, 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 19 (21) Huzly D, Umhau M, Bettinger D, Cathomen T, Emmerich F, Hasselblatt P, Hengel H, Herzog R, Kappert O, Maassen S, Schorb E, Schulz-Huotari C, Thimme R, Unmussig R, Wenzel J, Panning M (2014) Transfusion-transmitted hepatitis E in Germany, 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 19 (21)
4.
go back to reference Haim-Boukobza S, Ferey MP, Vetillard AL, Jeblaoui A, Pelissier E, Pelletier G, Teillet L, Roque-Afonso AM (2012) Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 57(6):1374–1378PubMedCrossRef Haim-Boukobza S, Ferey MP, Vetillard AL, Jeblaoui A, Pelissier E, Pelletier G, Teillet L, Roque-Afonso AM (2012) Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 57(6):1374–1378PubMedCrossRef
5.
go back to reference Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, Osterhaus AD, Cornelissen JJ, van der Eijk AA (2013) Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 122(6):1079–1086PubMedCrossRef Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, Osterhaus AD, Cornelissen JJ, van der Eijk AA (2013) Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 122(6):1079–1086PubMedCrossRef
6.
go back to reference Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Recher C, Izopet J (2012) Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 54(2):152–155PubMedCrossRef Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Recher C, Izopet J (2012) Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 54(2):152–155PubMedCrossRef
7.
go back to reference Koenecke C, Pischke S, Heim A, Raggub L, Bremer B, Raupach R, Buchholz S, Schulz T, Manns MP, Ganser A, Wedemeyer H (2012) Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country? Transpl Infect Dis 14(1):103–106PubMedCrossRef Koenecke C, Pischke S, Heim A, Raggub L, Bremer B, Raupach R, Buchholz S, Schulz T, Manns MP, Ganser A, Wedemeyer H (2012) Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country? Transpl Infect Dis 14(1):103–106PubMedCrossRef
8.
go back to reference Koenecke C, Pischke S, Beutel G, Ritter U, Ganser A, Wedemeyer H, Eder M (2014) Hepatitis E virus infection in a hematopoietic stem cell donor. Bone Marrow Transplant 49(1):159–160PubMedCrossRef Koenecke C, Pischke S, Beutel G, Ritter U, Ganser A, Wedemeyer H, Eder M (2014) Hepatitis E virus infection in a hematopoietic stem cell donor. Bone Marrow Transplant 49(1):159–160PubMedCrossRef
9.
go back to reference Tuncer HH, Rana N, Milani C, Darko A (2012) Al-Homsi SA Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol 18(16):1851–1860PubMedCentralPubMedCrossRef Tuncer HH, Rana N, Milani C, Darko A (2012) Al-Homsi SA Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol 18(16):1851–1860PubMedCentralPubMedCrossRef
Metadata
Title
Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host disease
Authors
Dominik Bettinger
Elisabeth Schorb
Daniela Huzly
Marcus Panning
Annette Schmitt-Graeff
Philipp Kurz
Hartmut Bertz
Jürgen Finke
Volker Brass
Robert Thimme
Peter Hasselblatt
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 2/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2163-4

Other articles of this Issue 2/2015

Annals of Hematology 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.